Flucytosine dose requirements in a patient receiving continuous veno-venous haemofiltration

Author： Thomson A.H. Shankland G. Clareburt C. Binning S.

ISSN： 0342-4642

Source： Intensive Care Medicine, Vol.28, Iss.7, 2002-07, pp. : 999-999

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Transfusion requirements during continuous veno-venous haemofiltration: – the importance of filter life

By Cutts Mark W.J. Thomas Antony N. Kishen Roop

Intensive Care Medicine, Vol. 26, Iss. 11, 2000-11 ,pp. : 1694-1697

Springer Publishing Company

Access to resources Recommend Favorite

Influence of continuous veno-venous hemofiltration on argatroban clearance in a patient with septic shock

By Schusterschitz N.

Intensive Care Medicine, Vol. 34, Iss. 7, 2008-07 ,pp. : 1350-1351

Springer Publishing Company

Access to resources Recommend Favorite

A pilot randomised controlled comparison of continuous veno–venous haemofiltration and extended daily dialysis with filtration: effect on small solutes and acid–base balance

By Baldwin Ian Naka Toshio Koch Bill Fealy Nigel Bellomo Rinaldo

Intensive Care Medicine, Vol. 33, Iss. 5, 2007-05 ,pp. : 830-835

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics of levofloxacin during continuous veno-venous hemofiltration

By Hansen Ernil Bucher Michael Jakob Wolfgang Lemberger Peter Kees Frieder

Intensive Care Medicine, Vol. 27, Iss. 2, 2001-02 ,pp. : 371-375

Springer Publishing Company

Access to resources Recommend Favorite

Lacosamide Pharmacokinetics in a Critically Ill Patient Receiving Continuous Venovenous Hemofiltration

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 38, Iss. 2, 2018-02 ,pp. : e17-e21

John Wiley & Sons Inc

Access to resources Recommend Favorite